Executive Profile

Michael G. Grey Co-Founder, Chief Executive Officer, President and Director, Lumena Pharmaceuticals, Inc.

Age	Total Calculated Compensation	This person is connected to 4 Board Members in 4 different organizations across 11 different industries. See Board Relationships
59	--

Background

Mr. Michael G. Grey, Mike is a Co-Founder of Lumena Pharmaceuticals, Inc. and serves as its Chief Executive Officer and President. Mr. Grey serves as an Observer at Ultragenyx. He served as the Chief Executive Officer and President at SGX Pharmaceuticals, Inc., since January 2005 and June 2003 respectively. Mr. Grey joined Lumena Pharmaceuticals, Inc. in 2010. Mr. Grey served as the Chief Executive Officer and President of Auspex Pharmaceuticals, Inc. since January 2009. ... He has 30 years of experience in the biopharmaceutical industry. Previously, Mr. Grey served as Executive Vice President and the Chief Business Officer of SGX Pharmaceuticals from April 1, 2001 to June 2003. From January 1999 to April 2001, he served as the President and Chief Executive Officer of Lion Biosciences Inc. Prior to joining Trega Biosciences Inc., Mr. Grey served as the President of BioChem Therapeutic Inc., from November 1994 to August 1998. In that role, he was responsible for all company operations including research, development, sales and marketing, finance, and human resources. Prior to joining BioChem Pharma Inc., Mr. Grey served as the Senior Vice President of Corporate Development at Titan Pharmaceuticals Inc. Since 1994, he served as the President and Chief Operating Officer at Ansan Inc. From 1974 to 1993, Mr. Grey served in various roles with Glaxo Inc. and Glaxo Holdings PLC, culminating in his position as Vice President of Corporate Development and Director of International Licensing. He served as the Chairman of Epimmune Inc. (formerly IDM Pharma, Inc) from December 2007 to June 2009. He has been a Director of Biomarin Pharmaceutical Inc. since December 14, 2005. He has been an Lead Independent Director of Horizon Pharma, Inc. since August 2012. Mr. Grey has been a Director of SGX Pharmaceuticals, Inc. since April 2001 and Horizon Pharma, Inc. since September 30, 2011. He serves as a Director of ChemNavigator.com(TM) Inc., Incellico Inc., an Executive Director at Lumena Pharmaceuticals, Inc. Mr. Grey serves as a Member of Scientific Advisory Board and Venture Partner at Pappas Ventures since January 11, 2010. Mr. Grey served as a Director of IDM Pharma, Inc. from July 1999 to June 2009, Lion Biosciences Inc. since December 1998, Achillion Pharmaceuticals, Inc. from November 2001 to September 2010, Auspex Pharmaceuticals, Inc. since January 2009 and Cortex Pharmaceuticals Inc. He holds a BS in Chemistry from the University of Nottingham, England in 1974.

Corporate Headquarters 2520 Meridian Parkway Durham, North Carolina 27713 United States Phone: 919-998-3300 Fax: 919-998-3301 Board Members Memberships Prior Cortex Pharmaceuticals Inc. Co-Founder, Chief Executive Officer, President and Director Lumena Pharmaceuticals, Inc. 1998-N/A Former Chief Executive Officer, President and Director LION Bioscience, Inc. 1999-N/A Former Director, Chairman of Governance and Nominating Committee, Member of Audit Committee, Member of Governance and Nominating Committee, Member of Finance Committee and Member of Special Committee Epimmune Inc. 1999-2009 Former Chairman, Chairman of Compensation Committee and Member of Audit Committee IDM Pharma, Inc. 2001-N/A Chief Executive Officer, President and Director SGX Pharmaceuticals, Inc. 2001-2010 Former Director and Member of Audit Committee Achillion Pharmaceuticals, Inc. 2005-Present Director, Member of Audit Committee and Member of Science & Technology Committee BioMarin Pharmaceutical Inc. 2009-N/A Former Chief Executive Officer, President and Director Auspex Pharmaceuticals, Inc. 2011-Present Director Selventa, Inc. 2011-Present Lead Independent Director, Member of Audit Committee and Member of Compensation Committee Horizon Pharma, Inc. Education BS 1974 Nottingham University Other Affiliations Pappas Ventures BioMarin Pharmaceutical Inc. Epimmune Inc. LION Bioscience, Inc. SGX Pharmaceuticals, Inc. Shire Canada Inc. Achillion Pharmaceuticals, Inc. IDM Pharma, Inc. Cortex Pharmaceuticals Inc. GlaxoSmithKline plc Selventa, Inc. Nottingham University Auspex Pharmaceuticals, Inc. Horizon Pharma, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.